Does metformin therapy reduce dementia risk in patients with type 2 diabetes?A study examines if cessation of metformin therapy is associated with dementia incidence and whether changes in blood glucose or insulin use affect the findings. POP QUIZ: Rinvoq for inflammatory bowel diseaseAll of the following statements about the use of Rinvoq (upadacitinib) in inflammatory bowel disease are true, EXCEPT for . . . Mpox vaccinations should be recommended for high-risk men, even after outbreak ends, advisers say More than 30,000 U.S. mpox cases were reported last year. Rinvoq (upadacitinib) now indicated for moderate/severely active Crohn’s disease It is the first oral Janus kinase (JAK) inhibitor indicated for acute treatment and maintenance therapy in both Crohn's disease and ulcerative colitis in adults. Engaging patients: your words matter If you are raising stopping or reducing a medication as an option, explain why this is being considered. Can at-home DNA tests predict how you’ll respond to your medications? Pharmacists look at the risks and benefits of pharmacogenetic testing to explain the variability in drug response Benzodiazepine-related toxicity: Ontario study In Canada, the prevalence of benzodiazepine use is estimated between 5% and 10%. Drug used in diabetes treatment Mounjaro helped dieters shed 60 pounds, study finds By comparison, a group of people who also dieted and exercised, but then received dummy shots, lost weight initially but then regained some. Which drugs can increase fall risk in older adults? Medication reviews and deprescribing are key interventions to prevent falls in older adults. Increase in anticholinergic burden linked to acute cardiovascular events in older adults Assessment of overall anticholinergic burden is essential for older patients taking multiple medications. First Previous 19 20 21 22 23 Next Last
